Xu, Jianfeng
Shi, Jiejun
Cui, Xiaodong
Cui, Ya http://orcid.org/0000-0003-1574-0928
Li, Jingyi Jessica http://orcid.org/0000-0002-9288-5648
Goel, Ajay http://orcid.org/0000-0003-1396-6341
Chen, Xi http://orcid.org/0000-0002-7995-6202
Issa, Jean-Pierre http://orcid.org/0000-0003-2258-5030
Su, Jianzhong
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG007538)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA228140)
Article History
Received: 19 February 2020
Accepted: 2 December 2020
First Online: 15 January 2021
Competing interests
: After completing the current studies at Baylor College of Medicine, J.X. became a full-time employee at Helio Health. W.L. is a consultant for Helio Health and ChosenMed. The remaining authors declare no competing interests.